New dry eye disease drug?

Improved Dry Eye Drugs for 2022 and Beyond

Reproxalap by Aldeyra Therapeutics is a new anti-inflammatory treatment without the common side effects of steroids. In a phase 3 clinical trial ...

New Drugs for Dry Eye and Demodex Blepharitis - Modern Optometry

The newest dry eye medication gaining FDA approval in 2023 is 100% perfluorohexyloctane (MIEBO; formerly known as NOV03, Novaliq/Bausch + Lomb). This first-in- ...

Reviewing the Dry Eye Treatment Pipeline - Review of Ophthalmology

Aldeyra submitted its New Drug Application for its drug Reproxalap in 2023. The FDA responded with some discrepancies over the clinical ...

Dry Eye Drugs: What's New and What's Next - Review of Optometry

Approved by the FDA in October 2021, Tyrvaya is the first nasal spray to treat the signs and symptoms of DED. It is applied to the inside of the ...

Latest treatment for dry eye syndrome: What is it?

They include OTC artificial tears, prescription eye drops targeting inflammation and tear production, and lifestyle adjustments.

Emerging Dry Eye Treatment Options (Last Updated: November 2024)

Emerging Dry Eye Treatment Options (Last Updated: November 2024) · Lumenis OptiLight Intense Pulse Light (IPL) · Meibomian Gland Probing or Maskin ...

2023 Pipeline Drugs Show Promise for Treating Dry Eye Disease

Reproxalap (Aldeyra Therapeutics, Lexington, MA) is another DED medication working its way through the approval process. A novel reactive ...

2023 New Treatments for Dry Eyes in LA - iLux²® - BlephEx® - IPL

Reproxalap takes a novel approach to treating dry eyes. It's a non-steroidal anti-inflammatory drug that aims to stabilize tear film by stopping RASP from ...

The Latest Treatment Advances in Dry Eye Syndrome - Healthline

Eye drops, topicals, oral medications · Perfluorhexyloctane (Miebo): Approved in 2023, this is the newest treatmentTrusted Source for dry eye ...

MIEBO® (perfluorohexyloctane ophthalmic solution) Dry Eye Drops

Discover MIEBO®, the first and only prescription eye drop that directly targets tear evaporation; the #1 cause of dry eye. Click to learn more!

Two New Therapies for Dry Eye Will Soon be on the Market

The FDA has approved two novel therapies for patients with dry eye disease: Vevye (previously CyclASol) is a water-free, preservative-free ...

Lifitegrast: a novel drug for patients with dry eye disease - PMC

Lifitegrast has a novel mechanism of action and is safe and effective for the treatment of dry eye disease. At this time, lifitegrast may be considered as an ...

Dry eye clinic offers new testing and treatments

One of the new technologies available is the Keratograph, which provides an image of the corneal surface and shows the condition of the ...

New FDA-Approved Therapies and Diagnostics for Dry Eye Disease

The third one is Xdemvy, [which] is lotilaner, and it is the only FDA-approved product for the treatment of blepharitis caused by Demodex mites.

A Look at the Dry-Eye Treatment Pipeline - Review of Ophthalmology

AZR-MD-001—a keratolytic ointment—has been developed for the treatment of meibomian gland dysfunction and evaporative dry-eye disease. A ...

New Hope for Extreme Dry Eye | John A. Moran Eye Center

"The solution, called perfluorohexyloctane, is designed to mimic a key natural function where meibomian glands produce a lipid-rich secretion ...

Not a Dry Eye in the House: An Overview of New Drugs

The 0.03 mg varenicline nasal spray (Tyrvaya®, Oyster Point Pharma, Inc., Princeton, NH) is FDA approved to treat signs and symptoms of dry eye ...

Novaliq Announces FDA Approval of VEVYE™ (Cyclosporine ...

CyclASol is an investigational new drug treatment for dry eye disease in patients not responding to tear substitutes. The Committee for ...

Advances in Dry Eye Disease Treatment - PMC - PubMed Central

A new device that was FDA-approved for the treatment of DED is the Intranasal Tear Neurostimulator (ITN, TrueTear®, Allergan, plc) (Figure 5). The ITN was ...

Xiidra - A New Treatment for Dry Eye Disease - Wills Eye Hospital

The U.S. Food and Drug Administration approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease, on.